Oligonucleotide microarrays reveal regulated genes related to inward arterial remodeling induced by urokinase plasminogen activator

Journal of Vascular Research

Volumn 46, Issue 3, 2009, Pages 177-187

  Plekhanova, Olga ^a   Berk, Bradford C ^c   Bashtrykov, Pavel ^a   Brooks, Andrew I ^c   Tkachuk, Vsevolod ^a,b   Parfyonova, Yelena ^a  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Inflammation; Inward arterial remodeling; Microarray; Oxidative stress; Urokinase plasminogen activator

Indexed keywords

OLIGONUCLEOTIDE; POLOXAMER; RECOMBINANT PLASMINOGEN ACTIVATOR; RECOMBINANT UROKINASE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; UROKINASE;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BALLOON CATHETER; BLOOD VESSEL; BOWMAN MEMBRANE; CAROTID ARTERY; CAROTID ARTERY INJURY; CLINICAL EVALUATION; CONTROLLED STUDY; DNA MICROARRAY; GEL; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INWARD VESSEL REMODELING; MALE; MITOCHONDRIAL RESPIRATION; MORPHOMETRICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; VASCULARIZATION; VASCULITIS;

ANIMALS; ARTERIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTERLEUKIN-1BETA; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED WKY; TUMOR NECROSIS FACTOR-ALPHA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 52149083948     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000156703     Document Type: Article

References (44)

1. Clowes AW, Reidy MA: Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia - a review. J Vasc Surg 1991;13:885-891.
2. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK: A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992;86:III47-III52.
3. Schwartz RS: Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodelling. Am J Cardiol 1998;81:14E-17E.
4. Carmeliet P, Moons L, Herbert JM, Crawley J, Lupu F, Lijnen R, Collen D: Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res 1997;81:829-839.
5. Plekhanova OS, Parfyonova YV, Bibilashvily RS, Stepanova VV, Erne P, Bobik A, Tkachuk VA: Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries. J Hypertens 2000;18:1065-1069.
6. Collen D: Ham-Wasserman lecture: Role of the plasminogen system in fibrin-homeostasis and tissue remodelling. Hematology 2001;1:1-9.
7. Parfyonova Ye, Plekhanova O, Solomatina M, Naumov V, Bobik A, Berk BC, Tkachuk V: Contrasting effects of urokinase and tissuetype plasminogen activators on neointima formation and vessel remodeling early after arterial injury. J Vasc Res 2004;41:268-276.
8. Okamoto E, Couse T, De Leon H, Vinten-Johansen J, Goodman RB, Scott NA, Wilcox JN: Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation 2001;104:2228-2235.
9. Shah PK: Inflammation, neointimal hyperplasia, and restenosis: s the leukocytes roll, the arteries thicken. Circulation 2003;107:2175-2177.
10. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A: Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001;21:327-334.
11. Plekhanova O, Parfyonova Y, Bibilashvily R, Domogatskii S, Stepanova V, Gulba DC, Agrotis A, Bobik A, Tkachuk V: Urokinase plasminogen activator augments cell proliferation and neointima formation in injured arteries via proteolytic mechanisms. Atherosclerosis 2001;159:297-306.
12. Brooks AI, Stein CS, Hughes SM, Heth J, McCray PM Jr, Sauter SL, Johnston JC, Cory-Slechta DA, Federoff HJ, Davidson BL: Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc Natl Acad Sci USA 2002;99:6216-6221.
13. Li C, Hung Wong W: Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2001;2:RESEARCH0032.
14. Welle S, Brooks AI, Thornton CA: Computational method for reducing variance with Affymetrix microarrays. BMC Bioinformatics 2002;3:23.
15. Hoffmann R, Seidl T, Dugas M: Profound effect of normalization on detection of differentially expressed genes in oligonucleotide microarray data analysis. Genome Biol 2002;3:RESEARCH0033.
16. Korshunov V, Nikonenko T, Tkachuk V, Brooks AI, Berk BC: Interleukin-18 and macrophage migration inhibitory factor are associated with increased carotid intima-media thickening. Arterioscler Thromb Vasc Biol 2006;26:295-300.
17. Loppnow H, Westphal E, Buchhorn R, Wessel A, Werdan K: Interleukin-1 and related proteins in cardiovascular disease in adults and children. Shock 2001;16(suppl 1):3-9.
18. Li H, Liang J, Castrillon DH, DePinho RA, Olson EN, Liu ZP: FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription. Mol Cell Biol 2007;27:2676-2686.
19. Kubica J, Kozinski M, Krzewina-Kowalska A, Zbikowska-Gotz M, Dymek G, Sukiennik A, Piasecki R, Bogdan M, Grzesk G, Chojnicki M, Dziedziczko A, Sypniewska G: Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions. Int J Mol Med 2005;16:173-180.
20. Menshikov M, Plekhanova O, Cai H, Chalupsky K, Parfyonova Y, Bashtrikov P, Tkachuk V, Berk BC: Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via redox-dependent pathways. Arterioscler Thromb Vasc Biol 2006;26:801-807.
21. Solomatina MA, Plekhanova OS, Menshikova MY, Ratner EI, Tkachuk VA, Parfyonova YV: Urokinase increases the content and activity of matrix metalloproteinases 2 and 9 during in vivo constrictive arterial remodeling. Bull Exp Biol Med 2005;139:283-286.
22. Pawlak K, Pawlak D, Mysliwiec M: Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Atherosclerosis 2007;190:199-204.
23. Haj-Yehia A, Nassar T, Sachais BS, Kuo A, Bdeir K, Al-Mehdi AB, Mazar A, Cines DB, Higazi AA: Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo. FASEB J 2000;14:1411-1422.
24. Mori E, Komori K, Yamaoka T, et al: Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits. Circulation 2002;105:2905-2910.
25. Boyle JJ: Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture. Curr Vasc Pharmacol 2005;3:63-68.
26. Levine B, Kalman J, Mayer L, Fillit HM, Packer M: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-241.
27. Böse D, Leineweber K, Konorza T, Zahn A, Bröcker-Preuss M, Mann K, Haude M, Erbel R, Heusch G: Release of TNFα during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. Am J Physiol Heart Circ Physiol 2007;292:H2295-H2299.
28. Seki N, Bujo H, Jiang M, Shibasaki M, Takahashi K, Hashimoto N, Saito Y: A potent activator of PPARalpha and gamma reduces the vascular cell recruitment and inhibits the intimal thickning in hypercholesterolemic rabbits. Atherosclerosis 2005;178:1-7.
29. Ono H, Ichiki T, Fukuyama K, Iino N, Masuda S, Egashira K, Takeshita A: AMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular smooth muscle cell migration. Arterioscler Thromb Vasc Biol 2004;24:1634-1639.
30. Selzman CH, Meldrum DR, Cain BS, Meng X, Shames BD, Ao L, Harken AH: Interleukin-10 inhibits postinjury tumor necrosis factor-mediated human vascular smooth muscle proliferation. J Surg Res 1998;80:352-356.
31. Voisard R, Voglic S, Baur R, Susa M, Koenig W, Hombach V: Leukocyte attack in a 3D human coronary in-vitro model. Coron Artery Dis 2001;12:401-411.
32. Overall CM, Lopez-Otin C: Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002;2:657-672.
33. Siwik DA, Colucci WS: Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail Rev 2004;9:43-51.
34. Kuzuya M, Iguchi A: Role of matrix metalloproteinases in vascular remodeling. J Atheroscler Thromb 2003;10:275-282.
35. Korshunov VA, Berk BC: Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol 2003;23:2185-2191.
36. Berk BC: Redox signals that regulate the vascular response to injury. Thromb Haemost 1999;82:810-817.
37. Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 1995;25:155-161.
38. Berk BC: Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 2001;81:999-1030.
39. 2- production in the pig coronary artery. Circulation 1997;96:3593-3601.
40. Cao D, Mizukami IF, Garni-Wagner BA, Kindzelskii AL, Todd RF 3rd, Boxer LA, Petty HR: Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. J Immunol 1995;154:1817-1829.
41. Sitrin RG, Pan PM, Harper HA, Todd RF 3rd, Harsh DM, Blackwood RA: Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils. J Immunol 2000;165:3341-3349.
42. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K: Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ 2006;13:730-737.
43. Nishikawa T, Araki E: Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal 2007;9:343-353.
44. Ungvari Z, Wolin MS, Csiszar A: Mechanosensitive production of reactive oxygen species in endothelial and smooth muscle cells: role in microvascular remodeling? Antioxid Redox Signal 2006;8:1121-1129.